 |
市場調査レポート
商品コード
1321896
糖尿病ケアデバイスの世界市場 (2023-2030年)：製品 (血糖モニタリングデバイス)・エンドユーザー別の規模・シェア・成長分析・予測Global Diabetes Care Devices Market Size, Share, Growth Analysis, By Product(Blood glucose monitoring devices), By End-use - Industry Forecast 2023-2030 |
||||||
| 糖尿病ケアデバイスの世界市場 (2023-2030年)：製品 (血糖モニタリングデバイス)・エンドユーザー別の規模・シェア・成長分析・予測 |
|
出版日: 2023年07月12日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の糖尿病ケアデバイスの市場規模は、2021年の267億米ドル、2022年の290億2,000万米ドルから、予測期間中は8.7%のCAGRで推移し、2030年には565億7,000万米ドルの規模に成長すると予測されています。
世界の糖尿病ケアデバイスの市場は、世界の糖尿病有病率の上昇により著しい成長を遂げています。これらのデバイスは、血糖値の管理とモニタリングに役立ち、患者の転帰を改善します。技術の進歩、糖尿病管理に対する意識の高まり、老人人口の増加などの要因が市場成長を促進しています。糖尿病治療のための低侵襲で携帯可能なデバイスに対する需要の高まりにより、市場は今後も拡大を続けると予想されています。
インスリン送達デバイスの使用の増加や、糖尿病有病率の増加により、市場は成長を遂げています。座りがちで不健康なライフスタイルにより、2型糖尿病の診断数が増加しています。国際糖尿病連合（IDF）によると、世界で約5億3,700万人の成人が糖尿病を患っています。さまざまな慢性疾患の発症につながる可能性があるため、糖尿病を効果的に管理・コントロールする必要性が高まっています。
糖尿病モニタリングデバイス部門の成長は、主にテストストリップや自己血糖モニタリングデバイスの採用の増加と、継続的なグルコースモニタリングへの需要の増加によって牽引されています。新興諸国では糖尿病に対する意識が高まっており、この動向の一因となっています。世界保健機関（WHO）の報告によると、世界人口の60％以上が十分な身体活動を欠いています。個人の健康意識が高まるなかで、参入事業者には有利な成長機会が示されています。
当レポートでは、世界の糖尿病ケアデバイスの市場を調査し、市場概要、市場への各種影響因子の分析、技術・イノベーションの動向、法規制環境、市場規模の推移・予測、各種区分・地域別の内訳、競合情勢、主要企業のプロファイルなどをまとめています。
目次
- エグゼクティブサマリー
- 調査手法
- 親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 主要市場洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料分析
- イノベーションマトリックス
- パイプライン製品の分析
- マクロ経済指標
- 主要投資分析
- 主要成功要因
- 競合の程度
- 市場力学・見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 市場力学
- 規制状況
- ポーターの分析
- 将来のディスラプションに関するSkyquestの特別な洞察
- 世界の糖尿病ケアデバイス市場：製品別
- 市場概要
- 血糖モニタリングデバイス
- 自己血糖モニタリングデバイス
- 持続血糖モニター
- テストストリップ
- ランセット
- インスリン送達デバイス
- インスリンポンプ
- チューブ付きポンプ
- チューブレスポンプ
- ペン (再利用可能・使い捨て)
- ペン型ニードル (標準・安全性)
- 注射器
- その他
- 世界の糖尿病ケアデバイス市場：エンドユーザー別
- 市場概要
- 病院
- 外来手術センター
- 診断センター
- 在宅ケア
- クリニック
- その他
- 世界の糖尿病ケアデバイス市場：地域別
- 市場概要
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東・アフリカ
- 競合情勢
- トップ5社の比較
- 主要企業の市場での位置付け
- 主要企業の採用戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア
- 主要企業プロファイル
- Abbott Laboratories
- Ascensia Diabetes Care
- Becton, Dickinson and Company
- Dexcom, Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- Insulet Corporation
- Johnson & Johnson
- Medtronic plc
- Nova Biomedical
- Novo Nordisk A/S
- Omron Healthcare, Inc.
- Sanofi S.A.
- Tandem Diabetes Care, Inc.
- Terumo Corporation
- Trividia Health, Inc.
- Ypsomed AG
- ARKRAY Inc.
- Glooko, Inc.
- GlySens Incorporated
Diabetes Care Devices Market size was valued at USD 26.7 billion in 2021 and is poised to grow from USD 29.02 billion in 2022 to USD 56.57 billion by 2030, growing at a CAGR of 8.7% in the forecast period (2023-2030).
The global diabetes care devices market is witnessing significant growth due to the rising prevalence of diabetes worldwide. These devices help in managing and monitoring blood glucose levels, improving patient outcomes. Factors such as technological advancements, increasing awareness about diabetes management, and the growing geriatric population are driving market growth. The market is expected to continue expanding in the coming years, driven by the increasing demand for minimally invasive and portable devices for diabetes care.
Top-down and bottom-up approaches were used to estimate and validate the size of Diabetes Care Devices and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Segments covered in this report:
Diabetes Care Devices Market is segmented on the basis of product type, end user, and region. By product, the Diabetes Care Devices Market segment is divided into blood glucose monitoring devices and insulin delivery devices. Blood glucose segment is further segmented into self-monitoring blood glucose meters, continuous glucose monitors, testing strips, and lancets. Insulin delivery devices are further segmented into insulin pumps (tubed pumps and tubeless pumps), pens (reusable and disposable), pen needles (standard and safety), syringes, and others. By end use, the market is segmented into hospitals, ambulatory surgery centers, diagnostic centers, home care, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and MEA.
Driver
The market is experiencing growth due to the increasing use of insulin-delivery devices and the growing prevalence of diabetes. Sedentary lifestyles and unhealthy choices have resulted in a rising number of Type-2 diabetes diagnoses. According to the International Diabetes Federation (IDF), approximately 537 million adults worldwide have diabetes, which can lead to the development of various chronic diseases. Consequently, there is a significant need to effectively manage and control diabetes.
Restrain
the global diabetes care devices market may encounter obstacles during the forecast period. Limited access to these devices in underdeveloped regions and challenges related to registration processes and reimbursement issues are expected to restrict market growth.
Trend
The growth of the diabetes monitoring devices segment is primarily driven by the increased adoption of test strips, self-monitoring blood glucose meters, and the growing demand for continuous glucose monitoring. Developing countries are witnessing a rise in awareness about the disease, contributing to this trend. The World Health Organization (WHO) reports that over 60% of the global population lacks sufficient physical activity. Active employment is considered vital for maintaining a healthy lifestyle, and the risk of developing type 2 diabetes increases with higher body weight across all age groups. As individuals become more health-conscious, the global market offers lucrative growth opportunities for industry players.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Diabetes Care Devices Market by Product
- Market Overview
- Blood glucose monitoring devices (Self-monitoring blood glucose meters
- continuous glucose monitors
- testing strips
- lancets)
- Insulin Delivery Devices (Insulin delivery devices {insulin pumps-tubed pumps
- tubeless pumps}
- pens{reusable
- disposable}
- pen needles {standard
- safety}
- syringes
- others)
- Global Diabetes Care Devices Market by End-use
- Market Overview
- Hospitals
- ambulatory surgery centres
- diagnostic centres
- home care
- clinics
- others
- Global Diabetes Care Devices Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ascensia Diabetes Care
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dexcom, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eli Lilly and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Insulet Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nova Biomedical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novo Nordisk A/S
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Omron Healthcare, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tandem Diabetes Care, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Trividia Health, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ypsomed AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ARKRAY Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Glooko, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlySens Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
